Cargando…
Reverse engineering of TLX oncogenic transcriptional networks identifies RUNX1 as tumor suppressor in T-ALL
The TLX1 and TLX3 transcription factor oncogenes play an important role in the pathogenesis of T-cell acute lymphoblastic leukemia (T-ALL)(1,2). Here we used reverse engineering of global transcriptional networks to decipher the oncogenic regulatory circuit controlled by TLX1 and TLX3. This Systems...
Autores principales: | Gatta, Giusy Della, Palomero, Teresa, Perez-Garcia, Arianne, Ambesi-Impiombato, Alberto, Bansal, Mukesh, Carpenter, Zachary W., De Keersmaecker, Kim, Sole, Xavier, Xu, Luyao, Paietta, Elisabeth, Racevskis, Janis, Wiernik, Peter H, Rowe, Jacob M, Meijerink, Jules P, Califano, Andrea, Ferrando, Adolfo A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3298036/ https://www.ncbi.nlm.nih.gov/pubmed/22366949 http://dx.doi.org/10.1038/nm.2610 |
Ejemplares similares
-
The TLX1 oncogene drives aneuploidy in T-cell transformation
por: De Keersmaecker, Kim, et al.
Publicado: (2010) -
ETV6 mutations in early immature human T cell leukemias
por: Van Vlierberghe, Pieter, et al.
Publicado: (2011) -
Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL
por: Tzoneva, Gannie, et al.
Publicado: (2013) -
Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia
por: Vanden Bempt, Marlies, et al.
Publicado: (2018) -
N-Me, a long range oncogenic enhancer in T-cell acute lymphoblastic leukemia
por: Herranz, Daniel, et al.
Publicado: (2014)